Insider Selling: OrthoPediatrics (NASDAQ:KIDS) Major Shareholder Sells 302,369 Shares of Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) major shareholder Jennifer Pritzker sold 302,369 shares of the company’s stock in a transaction that occurred on Thursday, September 10th. The stock was sold at an average price of $21.01, for a total transaction of $6,352,772.69. Following the sale, the insider directly owned 6,201,764 shares in the company, valued at approximately $130,299,061.64. The trade was a 4.65% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

OrthoPediatrics Price Performance

OrthoPediatrics stock opened at $21.56 on Friday. The company has a quick ratio of 2.17, a current ratio of 4.78 and a debt-to-equity ratio of 0.28. OrthoPediatrics Corp. has a 52-week low of $14.42 and a 52-week high of $26.74. The firm has a market cap of $562.93 million, a PE ratio of -12.83 and a beta of 0.99. The company’s 50 day moving average is $21.97 and its two-hundred day moving average is $19.02.

OrthoPediatrics (NASDAQ:KIDS) last posted its quarterly earnings results on Tuesday, August 4th. The company reported ($0.26) EPS for the quarter, topping the consensus estimate of ($0.30) by $0.04. OrthoPediatrics had a negative net margin of 15.72% and a negative return on equity of 8.10%. The business had revenue of $70.51 million during the quarter, compared to the consensus estimate of $68.21 million. On average, research analysts expect that OrthoPediatrics Corp. will post -1.14 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in KIDS. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of OrthoPediatrics by 6.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,995 shares of the company’s stock worth $246,000 after acquiring an additional 645 shares during the period. Waverly Advisors LLC increased its stake in shares of OrthoPediatrics by 6.7% during the second quarter. Waverly Advisors LLC now owns 12,366 shares of the company’s stock worth $237,000 after acquiring an additional 775 shares during the period. Russell Investments Group Ltd. raised its holdings in OrthoPediatrics by 433.1% during the third quarter. Russell Investments Group Ltd. now owns 1,402 shares of the company’s stock worth $26,000 after purchasing an additional 1,139 shares in the last quarter. BNP Paribas Financial Markets raised its holdings in OrthoPediatrics by 60.2% during the third quarter. BNP Paribas Financial Markets now owns 3,288 shares of the company’s stock worth $61,000 after purchasing an additional 1,235 shares in the last quarter. Finally, Legal & General Group Plc purchased a new position in shares of OrthoPediatrics during the 2nd quarter worth approximately $34,000. Hedge funds and other institutional investors own 69.05% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently commented on KIDS shares. Weiss Ratings raised OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, August 5th. BTIG Research increased their price target on OrthoPediatrics from $24.00 to $29.00 and gave the company a “buy” rating in a research report on Thursday, August 20th. TD Cowen reiterated a “buy” rating on shares of OrthoPediatrics in a research note on Monday, June 15th. Truist Financial set a $22.00 price objective on OrthoPediatrics in a research report on Wednesday, August 5th. Finally, Piper Sandler restated an “overweight” rating and set a $25.00 target price (up from $22.00) on shares of OrthoPediatrics in a research note on Wednesday, August 5th. Nine equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $26.44.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.